Product Information

NEORAL 100 MG GELATIN CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.7731 per EA under NDC 00078024815. Its NADAC has been published 480 times since Nov 28, 2013.

FDA first approved this application on Jul 14, 1995. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NEORAL 100 MG GELATIN CAPSULE

cyclosporine
$11.7731per EA

Strength

100 mg/1

NDC

00078024815

Classification

Brand

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

7/8/2026

Active Ingredients

CYCLOSPORINE

Approval Type

New Drug (NDA)

FDA Application

NDA050715

FDA Approved

7/14/1995

TE Code

AB1

On Market Since

7/14/1995

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for NEORAL 100 MG GELATIN CAPSULE has been published 480 times since Nov 28, 2013, and over the history we have for it it has risen 107.5%. The table below summarizes its recorded NADAC range and movement.

Current price$11.7731 per EA
All-time high$11.7731 (Aug 19, 2026)
All-time low$5.6731 (Nov 28, 2013)
52-week high$11.7731
52-week low$11.3143
Median price$7.9637
Average price$8.2991
Largest weekly change+18.1% (Jun 19, 2024)
Weeks tracked480
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

+2.0%

6M

+2.0%

1Y

+4.1%

3Y

+34.7%

5Y

+34.7%

All

+107.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NEORAL 100 MG GELATIN CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NEORAL 100 MG GELATIN CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $11.7731 per EA (NDC 00078024815), effective Aug 19, 2026.

How has the price of NEORAL 100 MG GELATIN CAPSULE changed over time?

Over the history we have for it, the NADAC for NEORAL 100 MG GELATIN CAPSULE has risen 107.5%. It has been tracked across 480 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEORAL 100 MG GELATIN CAPSULE?

Since Nov 28, 2013, the NADAC for NEORAL 100 MG GELATIN CAPSULE has ranged from a low of $5.6731 (Nov 28, 2013) to a high of $11.7731 (Aug 19, 2026), with a median of $7.9637 per EA.

Are there cheaper alternatives to NEORAL 100 MG GELATIN CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NEORAL 100 MG GELATIN CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures NEORAL 100 MG GELATIN CAPSULE?

NEORAL 100 MG GELATIN CAPSULE (NDC 00078024815) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.